Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cohen, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, S. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Bladder Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Comparative Pathology of Proliferative Lesions of the Urinary Bladder

Samuel M. Cohen

Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-3135, USA

Bladder neoplasia in humans consists of 2 diseases, a low-grade papillary tumor that does not invade or metastasize, and a high-grade lesion that usually invades and metastasizes. Bladder carcinogenesis in rats is most like the low-grade, papillary tumor, although it eventually does progress and invade. In the mouse, models are available that mimic each of these disease processes. Preneoplastic lesions in humans and rodents include various types of hyperplasia, proliferative cystitis, and dysplasia. These preneoplastic and neoplastic lesions arise throughout the urothelium, from the renal pelvis to the urethra, although most commonly in the bladder. Rarely, benign and malignant mesenchymal lesions occur in rats and mice, with a unique submucosal mesenchymal lesion present in some strains of mice. In addition, eosinophilic and clear inclusions in the superfi cial layer of urothelium in mice, which do not appear to be associated with toxicity or carcinogenesis, have been reported. An approach to evaluation of carcinogenic mechanisms involved in the urothelium is presented. It focuses on distinguishing between DNA reactive carcinogens vs those that act by increasing cell proliferation. Although rodent model s do not precisely mimic the human disease, they have provided useful model s for furthering our understanding of the carcinogenic process in the urothelium as it pertains to human diseases.

Key Words: Bladder • pathology • hyperplasia • papilloma • carcinoma • dysplasia • urothelium.

References

  • Johansson SL, Cohen SM (1996). Lower urinary tract. In: Anderson's Pathology, Vol 2, Damjanov I, Linder J (eds). Mosby, New York, pp 2143— 2165.
  • Cohen SM (1983). Pathology of experimental bladder cancer in rodents. In: The Pathology of Bladder Cancer, Vol II, Cohen SM, Bryan GT (eds). CRC Press, Boca Raton, FL, pp 1—40.
  • Droller MJ (1998). Bladder cancer: State of the art care. CA-A Cancer J For Clin 48: 269—284.
  • Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M., Esrig D., Miyao N., Tsai YC, Lerner SP, Schmutte C., Yang AS, Cote R., Dubeau L., Nichols PW, Hermann GG, Steven K., Horn T., Skinner DG, Jones PA (1994). Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54: 784—788.[Abstract/Free Full Text]
  • Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998). Bladder consensus conference committee: The World Health Organization/International Society of Urologic Pathology consensu s classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22: 1435—1448.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cordon-Cardo C., Shenfeld J., Dalbagni G. (1997). Genetic studies and molecular markers of bladder cancer. Sem Surg Oncol 13: 319—327.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Shirai T., Fukushima S., Hirose M., Ohshima M., Ito N. (1987). Epithelial lesions of the urinary bladder in three hundred and thirteen autopsy cases. Jpn J Cancer Res 78: 1073—1080.[Web of Science]
  • Wiener DP, Koss LG, Sablay B., Freed SZ( 1979). The prevalence and significance of Brunn's nests, cystitis cystica and squamous metaplasia in normal bladders. J Urol 122: 317—321.[Web of Science][Medline] [Order article via Infotrieve]
  • Ito N., Fukushima S. (1986). Carcinogenesis, urinary tract, rat. In: Urinary System, Jones TC, Mohr U, Hunt RD (eds). Springer-Verlag, Berlin, pp 17—322.
  • Kunze E., Schauer A., Schatt S. (1976). Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats. Z Krebsforsch 87: 139—160.[Web of Science]
  • Fukushima S., Arai M., Cohen SM, Jacobs JB, Friedell GH (1981). Scanning electron microscopy of cyclophosphamide-induce d hyperplasi a of the rat urinary bladder. Lab Invest 44: 89—96.[Web of Science][Medline] [Order article via Infotrieve]
  • Fukushima S., Cohen SM, Arai M., Jacobs JB, Friedell GH (1981). Scanning electron microscopic examination of reversible hyperplasia of the rat urinary bladder. Am J Pathol 102: 373—380.[Abstract]
  • Shirai T., Ikawa E., Fukushima S., Masui T., Ito N. (1986). Uracil-induced urolithiasis and the development of reversible papillomatosi s in the urinary bladder of F344 rats. Cancer Res 46: 2062—2067.[Abstract/Free Full Text]
  • Sakata T., Masui T., St. John M., Cohen SM (1988). Uracil-induced caculi and proliferative lesions of the mouse urinary bladder. Carcinogenesis 9: 1271—1276.[Abstract/Free Full Text]
  • Becci PJ, Thompson HJ, Strum JM, Brown CC, Sporn MB, Moon RC ( 1981). N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancer in C57BL/6 XDBA/2F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res 41: 927—932.[Abstract/Free Full Text]
  • Ogawa K., Uzvolgyi E., St. John MS, deOliveria ML, Arnold LL, Cohen SM (1998). Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N-butyl-N(4-hydroxybutyl) nitrosamine in B6D2F1 mice. Mol Carcinogenesis 21: 270—279.
  • Asamoto M., Mann AM, Cohen SM (1994). p53 Mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesi s in vivo. Carcinogenesis 15: 455—458.[Abstract/Free Full Text]
  • Masui T., Don I., Takada N., Ogawa K., Shirai T., Fukushima S. (1994). p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine. Carcinogenesis 15: 2379— 2381.[Abstract/Free Full Text]
  • Jacobs JB, Cohen SM, Arai M., Friedell GH, Bulay O., Urman HK (1976). Chemically induced smooth muscle tumors of the mouse urinary bladder. Cancer Res 36: 2396—2398.[Abstract/Free Full Text]
  • Halliwell W. (in press). Proliferative mesenchymal lesions (submucosal mesenchymal tumor) of the urinary bladder. Env Hlth Persp.
  • Arnold LL, Christenson R., Cano M., St. John MK, Wahl BS, Cohen SM (1997). Tributyl phosphate effects on urine and bladder epithelium in male Sprague-Dawley rats. Fund Applied Toxicol 40: 247—255.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cohen SM (1998). Cell proliferation and carcinogenesis. Drug Met Rev 30: 339—357.[Web of Science][Medline] [Order article via Infotrieve]
  • Clayson DB, Fishbein L., Cohen SM (1995). The effect of stones and other physical factors on the induction of rodent bladder cancer. Fd Chem Toxicol 33: 771—784.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Engelmann U., Schramek P., Baum HP, Wertmann B., Grun M., Jacobi GH (1987). Bladder carcinogenesi s in portacaval shunt rats. Urol Int 42: 165— 169.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jull JW (1979). The effect of time on the incidence of carcinomas obtained by the implantation of paraffi n wax pellets into mouse bladder. Cancer Lett 6: 21—25.[Medline] [Order article via Infotrieve]
  • Cohen SM (1995). The role of urinary physiology and chemistry in bladder carcinogenesis. Fd Chem Toxicol 33: 715—730.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Burin GJ, Gibb HJ, Hill RN ( 1995). Human bladder cancer: evidence for a potential irritation-induced mechanism. Fd Chem Toxicol 33: 785—795.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rodent Bladder Carcinogenesis Working Group (1995). Urinary bladder carcinogenesis: implications for risk assessment. Fd Chem Toxicol 33: 797— 802.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cohen SM, Fisher MJ, Sakata T., Cano M., Schoenig GP, Chappel CI, Garland EM (1990). Comparative analysis of the proliferative response of the rat urinary bladder to sodium saccharin by light and scanning electron microscopy and autoradiography. Scan Microsc 4: 135—142.
  • Smith RA, Christenson WR, Bartels MJ, Arnold LL, St. John MK, Cano M., Wahle BS, McNett DA, Cohen SM (1998). Urinary physiologic and chemical metabolic effects on the urothelial cytotoxicity and potential genotoxicity of o-phenylpheno l in male rats. Toxicol Appl Pharmacol150: 402—413.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cohen SM (1999). Calcium phosphate-containin g urinary precipitate in rat urinary bladder carcinogenesis. International Agency for Research on Cancer, Lyon, France, IARC Sci Publ 147: 175—189.[Medline] [Order article via Infotrieve]
  • Ellwein LB, Cohen SM (1990). The health risks of sacchharin revisited. Crit Rev Toxicol 20: 311—326.[Web of Science][Medline] [Order article via Infotrieve]
  • Pauli BU, Alroy J., Weinstein RS (1983). Theultrastructure andpathobiology of urinary bladder cancer. In: The Pathology of Bladder Cancer, Vol II, Cohen SM, Bryan GT (eds). CRC Press, Boca Raton, FL, pp 41—140.
  • Wu XR, Lin JH, Walz T., Haner M., Yu J., Aebi U., Sun TT (1994). Mammalian uroplakins. J Biol Chem 269: 13716—13724.[Abstract/Free Full Text]
  • OgawaK., SunT-T., CohenSM ( 1996). Analysis of differentiation-associated proteins in rat bladder carcinogenesis. Carcinogenesis 17: 961—965.[Abstract/Free Full Text]
  • Johansson SL, Cohen SM (1997). Epidemiology and etiology of bladder cancer. Sem Surg Oncol 13: 291—298.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • El-Bolkainy MN (1983). Schistosomiasis and bladder cancer. In: The Pathology of Bladder Cancer, Vol I, Cohen SM, Bryan GT (eds). CRC Press, Boca Raton, FL, pp 57—89.
  • Steineck G., Plato N., Alfredsson L., Norell SE (1989). Industry-related urothelial carcinogens: Application of a job-exposure matrix to census data. Am J Ind Med 16: 209—224.[Web of Science][Medline] [Order article via Infotrieve]
  • Birt DF, Julius AD, Hasegawa R., St. John MS, Cohen SM (1987). Effect of L-tryptophan excess and vitamin B6 defi ciency on urinary bladder cancer promotion. Cancer Res 47: 1244—1250.[Abstract/Free Full Text]
  • IARC Working Group ( 1999). Consensus Report. International Agency for Research on Cancer, Lyon, France, IARCScientific Publications 147: 1—32.
  • 9th Report on Carcinogens (2000). U.S. Department of Health and Human Services, National Toxicology Program, Research Triangle Park, NC, pp B3—B4.
  • IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (1999). Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances. International Agency for Research on Cancer, Lyon, France, 73: 516—624.
  • Cohen SM, Ellwein LB (1990). Cell proliferation in carcinogenesis. Science 249: 1007—1011.[Abstract/Free Full Text]
  • Cohen SM (1998). Urinary bladder carcinogenesis. Toxicol Pathol 26: 121— 127.[Abstract/Free Full Text]
  • US Environmental Protection Agency (1997). Report on the expert panel on arsenic carcinogenicity. National Center for Environmental Assessment, US Environmental Protection Agency, Washington, DC.
  • Arnold LL, Cano M., St. John MK, Eldan M., van Gemert M., Cohen SM (1999). Effects of dietary dimethylarsinic acid on the urine and urothelium of rats. Carcinogenesis 20: 101—109.
  • Cohen SM, Cano M., Johnson LS, St. John MK, Asamoto M., Garland EM, Thyssen JH, Sangha GK, Van Goethem DL (1994). Mitogenic effects of propoxur on male rat bladder urothelium. Carcinogenesis 15: 2593— 2597.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 30, No. 6, 663-671 (2002)
DOI: 10.1080/01926230290166751


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cohen, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, S. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Bladder Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?